Valuation: Doxa AB

Market Cap 456M 48.05M 41.48M 38.92M 35.45M 66.65M 4.59B 67.58M 179M 2.3B 180M 177M 7.66B P/E 2024
-0.38x
P/E 2025 -1.69x
Enterprise Value 1.96B 206M 178M 167M 152M 286M 19.71B 290M 767M 9.87B 774M 757M 32.84B EV / Sales 2024
290x
EV / Sales 2025 102x
Free-Float
-
Yield 2024 *
-
Yield 2025 -
1 day-1.01%
1 week-0.72%
Current month-3.91%
1 month-4.71%
3 months-14.75%
6 months-12.69%
Current year-21.82%
1 week 0.34
Extreme 0.3395
0.35
1 month 0.34
Extreme 0.3395
0.38
Current year 0.34
Extreme 0.3395
0.46
1 year 0.34
Extreme 0.3395
0.58
3 years 0.32
Extreme 0.32
3.98
5 years 0.32
Extreme 0.32
18.4
10 years 0.32
Extreme 0.32
18.4
Manager TitleAgeSince
Chief Executive Officer 52 09/10/2024
Director of Finance/CFO - 27/04/2026
Director TitleAgeSince
Chairman 66 31/12/2023
Director/Board Member 62 28/04/2025
Director/Board Member 63 28/04/2025
Date Insider Type Main position Quantity % Market Cap.
14/07/26 Buy 100,000 0.0078%
28/02/26 Buy 100,000 0.0078%
01/01/26 Buy

Chairman

1,969,790 0.1532%
Change 5-day change 1-year change 3-year change Capi.($)
-1.01%-0.72%-35.94%-90.86% 47.98M
+0.60%+1.56%+27.39%+30.88% 43.02B
-0.70%+3.47%+2.60%+4.01% 31.08B
-0.05%-4.12%+16.19%+116.69% 27.8B
-0.90%-4.17%-24.78%+61.82% 26.76B
-0.55%-4.98%-8.15%+44.71% 24.64B
-0.65%-3.18%-34.51%-61.57% 20.84B
+2.00%-2.09%+22.92%+8.00% 20.07B
-0.65%-4.05%+9.43%+87.24% 19.63B
-0.45%+2.13%-6.68%-19.16% 18.8B
Average -0.24%-1.44%-3.15%+18.18% 23.27B
Weighted average by Cap. -0.13%-1.22%+2.77%+33.00%

Financials

2024 2025
Net sales 15.5M 1.63M 1.41M 1.32M 1.2M 2.26M 156M 2.3M 6.07M 78.2M 6.13M 6M 260M 20.3M 2.14M 1.85M 1.73M 1.58M 2.97M 204M 3.01M 7.95M 102M 8.03M 7.85M 341M
Net income -1.72B -182M -157M -147M -134M -252M -17.35B -255M -675M -8.69B -681M -667M -28.92B -335M -35.33M -30.5M -28.61M -26.06M -49M -3.38B -49.68M -131M -1.69B -133M -130M -5.63B
Net Debt 3.56B 375M 324M 304M 277M 521M 35.89B 528M 1.4B 17.98B 1.41B 1.38B 59.81B 1.5B 158M 136M 128M 117M 219M 15.11B 222M 588M 7.57B 593M 581M 25.19B
Logo Doxa AB
Doxa AB is a Sweden-based company which develops products based on bio-active ceramics. The Company develops, manufactures and commercializes products based upon its technology platform of calcium aluminate hydrate and bioactive ceramics. Activities are divided into the therapy areas of orthopedics and odontology. Research areas within orthopedics are methods for treating fractures resulting from osteoporosis, reconstructive orthopedics and coating of implants. Research areas within odontology are tooth restoration and implant fixation.
Employees
26
Date Price Change Volume
17/08/26 SEK 0.3440 -1.01% 292,541
14/08/26 SEK 0.3475 +1.76% 394,514
13/08/26 SEK 0.3415 -2.01% 262,866
12/08/26 SEK 0.3485 +1.90% 49,325
11/08/26 SEK 0.3420 -1.30% 157,886
  1. Stock Market
  2. Stocks
  3. DOXA Stock